FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental NDA for Advair Diskus (fluticasone propionate and salmeterol) submitted by GlaxoSmithKline LLC. The approval indicates the FDA has a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ADVAIR DISKUS (fluticasone propionate and salmeterol)

Snippet

SUPPL AP for ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL)